Enanta Pharmaceuticals
ENTA
#8002
Rank
โ‚ฌ0.34 B
Marketcap
11,87ย โ‚ฌ
Share price
-0.44%
Change (1 day)
113.06%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚ฌ43.92 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ69.21 Million. In 2025 the company made an earning of -โ‚ฌ55.38 Million, an increase over its 2024 earnings that were of -โ‚ฌ84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ43.92 Million-20.69%
2025 -โ‚ฌ55.38 Million-34.07%
2024 -โ‚ฌ84 Million-23.87%
2023 -โ‚ฌ0.12 Billion4.39%
2022 -โ‚ฌ0.11 Billion-4.4%
2021 -โ‚ฌ0.12 Billion91.12%
2020 -โ‚ฌ57.85 Million-407.13%
2019 โ‚ฌ18.83 M-78.63%
2018 โ‚ฌ88.15 M117.97%
2017 โ‚ฌ40.44 M-574.65%
2016 -โ‚ฌ8.53 Million-110.83%
2015 โ‚ฌ78.69 M-4.5%
2014 โ‚ฌ82.4 M-638.53%
2013 -โ‚ฌ15.31 Million-137.98%
2012 โ‚ฌ40.28 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.49 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.66 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚ฌ5.17 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.38 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.38 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.31 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA